How Long Does Semaglutide Take to Work? A Week-by-Week Results Timeline

Most people begin to notice reduced appetite and fewer food cravings within the first 1 to 2 weeks of starting semaglutide. Visible weight loss — meaning a noticeable drop on the scale — typically begins between weeks 4 and 8 as the dose is increased. Significant results, such as losing 10 to 15 percent of body weight, generally occur over 3 to 6 months at a therapeutic dose. Maximum results are usually reached by 12 to 16 months of continued treatment.

Not losing weight in the first 4 weeks on semaglutide is completely normal. At this stage, you are likely still on the lowest starting dose of 0.25 mg per week, which is a titration dose designed to let your body adjust — not yet a therapeutic weight loss dose. Meaningful weight loss typically begins once you reach 0.5 mg to 1.0 mg per week or higher. If you have been on a therapeutic dose for 8 or more weeks and still see no results, speak with your prescriber about increasing your dose or evaluating other factors such as diet, activity level, or potential underlying metabolic conditions.

Appetite suppression from semaglutide is often the first effect people notice, typically starting within 3 to 7 days of the first injection. Many patients describe a significant quieting of 'food noise' — the constant mental preoccupation with eating — within the first two weeks. The appetite-suppressing effects generally become more pronounced as the dose increases during the titration phase.

In the first month on semaglutide, most people lose between 2 and 5 pounds, primarily because the starting dose (0.25 mg) is not yet at a therapeutic weight loss level. Some individuals lose more if they also make significant dietary changes. The primary goal of the first four weeks is tolerability and adjustment, not rapid weight loss. Expect more meaningful weight loss to accelerate between months 2 and 6 as your dose reaches therapeutic levels.

Yes, individual responses to semaglutide vary significantly. Factors that can influence how quickly semaglutide works include your starting body weight, your baseline metabolic rate, whether you have insulin resistance or type 2 diabetes, your diet and physical activity level, and your unique biological response to the GLP-1 receptor pathway. Some people are 'super responders' who see rapid results, while others may need higher doses or longer durations to see significant progress. Working with a healthcare provider ensures your dosing is optimized for your specific profile.

If you stop taking semaglutide, appetite suppression ends within days and the medication clears your system over approximately 5 to 7 weeks due to its long half-life. Clinical studies show that most people regain a significant portion of their lost weight — typically 50 to 70 percent — within 12 to 18 months of stopping treatment. This is why semaglutide is generally considered a long-term or ongoing treatment, not a short-term solution. Talk to your prescriber before stopping.

While you cannot safely rush the dose titration schedule, you can maximize your results on semaglutide by combining treatment with a protein-rich, reduced-calorie diet, staying well-hydrated, engaging in regular strength training and cardio exercise, getting adequate sleep (7 to 9 hours per night), and managing stress. These lifestyle factors work synergistically with semaglutide to enhance fat loss and preserve muscle mass. Discuss any questions about your dosing schedule or results with your prescriber during telehealth consultations.

Semaglutide works through the same GLP-1 receptor mechanism for both type 2 diabetes management and weight loss. However, the dose used for weight loss (up to 2.4 mg per week as Wegovy) is generally higher than the dose approved for diabetes (up to 1.0 mg per week as Ozempic). People with type 2 diabetes may notice blood sugar improvements within the first 1 to 2 weeks, while weight loss follows the same general timeline as for non-diabetic patients. Your prescriber will determine the appropriate dose and treatment goals for your individual situation.

Both semaglutide and tirzepatide follow similar timelines for initial appetite suppression and early weight loss. However, tirzepatide's dual GLP-1 and GIP receptor action tends to produce greater overall weight loss results — averaging 20 to 22 percent of body weight versus approximately 15 percent for semaglutide — over the same treatment period. The timeline for noticing effects is similar: appetite changes within the first 1 to 2 weeks and measurable weight loss from weeks 4 to 8 onward. For a deeper comparison, see our guide on semaglutide vs tirzepatide.

Yes, this is completely normal for many patients. The first 2 to 4 weeks can include nausea, fatigue, or mild gastrointestinal discomfort as your body adjusts to semaglutide. These side effects typically peak during the first month and gradually improve as your body adapts to the medication. Eating smaller meals, avoiding greasy or rich foods, staying hydrated, and taking your injection with food can all help reduce these temporary symptoms. Most patients report that side effects improve significantly by weeks 6 to 8.